A new algorithm developed by researchers at New York-based Mount Sinai School of Medicine aims to help scientists to better understand why different drugs have certain side effects on patients, the ...
Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...
LOS ANGELES, CA - March 10, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results